UBS Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
1,145,435
+416,613
| +57% | +$1.14M | ﹤0.01% | 3451 |
|
|
2025
Q1 | $1.22M | Buy |
728,822
+279,969
| +62% | +$470K | ﹤0.01% | 4041 |
|
|
2024
Q4 | $732K | Buy |
448,853
+144,115
| +47% | +$235K | ﹤0.01% | 4447 |
|
|
2024
Q3 | $1.27M | Buy |
304,738
+64,100
| +27% | +$267K | ﹤0.01% | 3394 |
|
|
2024
Q2 | $1.31M | Sell |
240,638
-133,089
| -36% | -$727K | ﹤0.01% | 3173 |
|
|
2024
Q1 | $3.74M | Buy |
373,727
+66,307
| +22% | +$663K | ﹤0.01% | 2449 |
|
|
2023
Q4 | $1.25M | Buy |
307,420
+199,080
| +184% | +$812K | ﹤0.01% | 3267 |
|
|
2023
Q3 | $419K | Sell |
108,340
-39,050
| -26% | -$151K | ﹤0.01% | 3728 |
|
|
2023
Q2 | $878K | Sell |
147,390
-15,653
| -10% | -$93.3K | ﹤0.01% | 3410 |
|
|
2023
Q1 | $533K | Sell |
163,043
-178,831
| -52% | -$585K | ﹤0.01% | 3653 |
|
|
2022
Q4 | $1.35M | Buy |
341,874
+282,041
| +471% | +$1.11M | ﹤0.01% | 2890 |
|
|
2022
Q3 | $359K | Sell |
59,833
-167,166
| -74% | -$1M | ﹤0.01% | 3637 |
|
|
2022
Q2 | $1.46M | Sell |
226,999
-80,812
| -26% | -$520K | ﹤0.01% | 2602 |
|
|
2022
Q1 | $2.54M | Buy |
307,811
+196,844
| +177% | +$1.63M | ﹤0.01% | 2472 |
|
|
2021
Q4 | $1.72M | Buy |
110,967
+55,962
| +102% | +$866K | ﹤0.01% | 2996 |
|
|
2021
Q3 | $1.24M | Buy |
55,005
+46,367
| +537% | +$1.04M | ﹤0.01% | 3091 |
|
|
2021
Q2 | $170K | Buy |
8,638
+4,086
| +90% | +$80.4K | ﹤0.01% | 4451 |
|
|
2021
Q1 | $153K | Buy |
+4,552
| New | +$153K | ﹤0.01% | 4673 |
|